公开(公告)号：WO1997017934A1

公开(公告)日：1997-05-22

申请号：PCT/US1996017615

申请日：1996-11-04

Applicant: ABBOTT LABORATORIES

Inventor： ABBOTT LABORATORIES ,  RHODES, Lawrence, J. ,  KLANDRUD, Kathee, E.

IPC: A61J01/00

CPC classification number: A61J1/00

Abstract: A method for storing a solution containing acyclovir and a pharmaceutical product containing an acyclovir solution. The method includes the steps of providing a predetermined volume of an acyclovir solution suitable for parenteral administration to a patient and providing a container constructed to contain the predetermined volume. The container is constructed from a material containing polymethylpentene and defines an opening. The acyclovir solution is placed into the container. The method further includes the step of providing a stopper configured to seal fluidly the opening defined by the container. The container is then sealed using the stopper. The pharmaceutical product includes an acyclovir solution contained by a container constructed from a material containing polymethylpentene. The container defines an opening therethrough. The product further includes a stopper coated with a fluorinated resin. The stopper fluidly seals the opening defined by the container.

Abstract translation: 一种用于储存含有阿昔洛韦和含有阿昔洛韦溶液的药物的溶液的方法。 该方法包括以下步骤：提供适合于向患者肠胃外给药的预定体积的阿昔洛韦溶液，并提供构造成容纳预定体积的容器。 容器由含有聚甲基戊烯的材料构成并限定开口。 将阿昔洛韦溶液置于容器中。 该方法进一步包括提供一个止动器的步骤，该止动器构造成将流体密封由容器限定的开口。 然后使用塞子密封容器。 药物产品包括由含有聚甲基戊烯的材料构成的容器所含的阿昔洛韦溶液。 容器限定穿过其中的开口。 该产品还包括涂覆有氟化树脂的塞子。 止动器流体地密封由容器限定的开口。

公开(公告)号：EP0865267A1

公开(公告)日：1998-09-23

申请号：EP96937882.0

申请日：1996-11-04

Applicant: Abbott Laboratories

Inventor： RHODES, Lawrence, J. ,  KLANDRUD, Kathee, E.

IPC: B65D39 ,  A61J1

CPC classification number: A61J1/00

Abstract: A method for storing a solution containing acyclovir and a pharmaceutical product containing an acyclovir solution. The method includes the steps of providing a predetermined volume of an acyclovir solution suitable for parenteral administration to a patient and providing a container constructed to contain the predetermined volume. The container is constructed from a material containing polymethylpentene and defines an opening. The acyclovir solution is placed into the container. The method further includes the step of providing a stopper configured to seal fluidly the opening defined by the container. The container is then sealed using the stopper. The pharmaceutical product includes an acyclovir solution contained by a container constructed from a material containing polymethylpentene. The container defines an opening therethrough. The product further includes a stopper coated with a fluorinated resin. The stopper fluidly seals the opening defined by the container.